Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Silvana Lalo"'
Autor:
Lentzsch, Suzanne, O'Sullivan, Amy, Kennedy, Ryan C., Abbas, Mohammad, Dai, Lijun, Pregja, Silvana Lalo, Burt, Steve, Boyiadzis, Michael, Roodman, G. David, Mapara, Markus Y., Agha, Mounzer, Waas, John, Shuai, Yongli, Normolle, Daniel, Zonder, Jeffrey A.
Publikováno v:
In Blood 17 May 2012 119(20):4608-4613
Autor:
Nalini Janakiraman, D Benson, Jeffrey Matous, Markus Y. Mapara, Vaishali Sanchorawala, R. M. Snyder, Howard R. Terebelo, Judith Abrams, David J. Monsma, C. Gasparetto, Silvana Lalo, Jeffrey A. Zonder
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S74-S75
Autor:
Suzanne Lentzsch, Amy O'Sullivan, Ryan Kennedy, Mohammad Abbas, Navkiranjit Gill, Lijun Dai, Carrie Andreas, Diane Gardner, Silvana Lalo Pregja, Steve Burt, Robert L. Redner, Robert Volkin, G. David Roodman, Markus Y. Mapara, J. Franklin Viverette, Mounzer Agha, John K. Waas, Yongli Shuai, Daniel Normolle, Jeffrey A. Zonder
Publikováno v:
Blood. 118:304-304
Abstract 304 Background: Bendamustine is a bifunctional alkylating agent that is approved for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma. This first multicenter, phase I/II trial investigated the combination of
Autor:
Suzanne Lentzsch, Markus Y. Mapara, Ryan Kennedy, Mounzer Agha, Diane Gardner, Navkiranjit Gill, Silvana Lalo, Robert Volkin, Jeffrey A. Zonder, Frank Viverette, Carrie Andreas, David Roodman, Robert L. Redner, Steve Burt, Amy K. O’Sullivan
Publikováno v:
Blood. 116:989-989
Abstract 989 Background: Lenalidomide is an analog of thalidomide that has significant clinical activity in combination with dexamethasone in patients with relapsed or refractory multiple myeloma (MM). Bendamustine is a bifunctional alkylating agent
Autor:
Nishant Tageja, Craig P. Webb, Jeffrey Matous, Judith Abrams, Rachel M. Snyder, Catherine Sellers, Vaishali Sanchorawala, Markus Y. Mapara, Silvana Lalo, Howard R. Terebelo, Jeffrey A. Zonder, Cristina Gasparetto, David J. Monsma, Nalini Janakiraman
Publikováno v:
Blood. 114:746-746
Abstract 746 Introduction: Primary systemic amyloidosis (AL) is a monoclonal plasma cell disorder associated with progressive organ dysfunction and short survival. Standard therapy for patients (pts) not eligible for autologous stem cell transplant (
Autor:
David Roodman, Silvana Lalo, Markus Y. Mapara, Suzanne Lentzsch, Amy K. O’Sullivan, Steve Burt, Robert L Volkin, Robert L. Redner, Ryan Kennedy, Jeffrey A. Zonder, Diane Gardner, Carrie Kruppa
Publikováno v:
Blood. 114:1856-1856
Abstract 1856 Poster Board I-882 Background: Lenalidomide is an analog of thalidomide that has shown significant clinical activity in patients with relapsed or refractory multiple myeloma (MM), both as a single agent and in combination with dexametha
Autor:
Lentzsch, Suzanne, O'Sullivan, Amy *, Kennedy, Ryan *, Abbas, Mohammad *, Gill, Navkiranjit *, Dai, Lijun *, Andreas, Carrie *, Gardner, Diane *, Pregja, Silvana Lalo *, Burt, Steve *, Redner, Robert L., Volkin, Robert *, Roodman, G. David *, Mapara, Markus Y., Viverette, J. Franklin *, Agha, Mounzer, Waas, John K., Shuai, Yongli *, Normolle, Daniel *, Zonder, Jeffrey A.
Publikováno v:
In Blood 18 November 2011 118(21):304-304